2015-2019 Europe Cell Surface Markers Testing: Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers - France, Germany, Italy, Spain, UK

September 2015 | 125 pages | ID: 20F8B007F52EN
Venture Planning Group

Abstracts

Complete report $3,850. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country. RationaleThe use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment. The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 125 pages and 24 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Introduction
B. Thrombin Time: Clinical Significance and Current Laboratory Procedures
C. Instrumentation Review
  Introduction
  Benk Hemolab
  Benk TRT Thrombotimer
  Bio/Data MCA
  Bio/Data MCA
  Bio/Data PAP-4C D/4D/4C
  Cardiovascular Diagnostics COAG
  Diagnostica Stago STA Compact
  Diagnostica Stago STA-R
  Diagnostica Stago Star 4/8
  Helena Laboratories Cascade
  Helena Laboratories Cascade M
  Helena Laboratories PACKS-4
  Helena THOR
  Instrumentation Laboratory ACL 100 and 1000 series
  Instrumentation Laboratory ACL6000
  Instrumentation Laboratory ACL7000
  Instrumentation Laboratory ACL9000
  Instrumentation Laboratory Electra 1000C
  Instrumentation Laboratory Electra 1400C
  Instrumentation Laboratory Electra 1600/C
  Instrumentation Laboratory Electra 1800C
  Instrumentation Laboratory Futura
  ITC Hemochron 8000
  Roche Diagnostics CoaguChek
  Siemens BCS
  Siemens BCT
  Siemens BF II/Fibrintimer Series
  Sysmex CA-50
  Sysmex CA-500
  Sysmex CA-1500
  Sysmex CA-5000/CA-1000
  Sysmex CA-6000
  Sysmex CA-7000
  Teco Coatron II/Jr./AccuStasis 5000
  Trinity Biotech Amax CS190
  Trinity Biotech Amax CS400
  Trinity Biotech Coag-A-Mate Max
  Trinity Biotech KC 40, 4A, 1A Series
  Trinity Biotech MDA
  Trinity Biotech Coag-A-Mate MTX
  Trinity Biotech Coag-A-Mate RA4
  Trinity Biotech Coag-A-Mate XC/Plus
  Trinity Biotech Coag-A-Mate XM
D. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
     Overview
     ELISA
     EMIT
     Dot Immunobinding Assays
     Capillary Immunoassays
     Enzyme Amplification
     Electrochemical Immunoassay
    d. Fluorescent Immunoassays
     Fluorescence Polarization
     Time-Resolved Pulse Fluorescence
     Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Microcomputers
  5. Automation
  6. Robotics
  7. DNA Probes
    a. Overview
    b. Amplification Methods
     PCR
     Ligase Chain Reaction
     Branched DNA
     Q-Beta Replicase
     NASBA
     SDA
     3 SR
     HPA
     Two-Tiered System
     LAT
  8. Artificial Intelligence
  9. Dry Chemistry
  10. Biosensors

III. FRANCE: TEST VOLUME FORECASTS BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME FORECASTS BY MARKET SEGMENT

V. ITALY: TEST VOLUME FORECASTS BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME FORECASTS BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME FORECASTS BY MARKET SEGMENT

VIII. UK: TEST VOLUME FORECASTS BY MARKET SEGMENT

IX. USA: TEST VOLUME FORECASTS BY MARKET SEGMENT

X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

XI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIII. COMPETITIVE ASSESSMENTS

Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech
ZyCare

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Thrombin Time Tests
France Thrombin Time Test Volume Forecasts by Market Segment
Germany Thrombin Time Test Volume Forecasts by Market Segment
Italy Thrombin Time Test Volume Forecasts by Market Segment
Japan Thrombin Time Test Volume Forecasts by Market Segment
Spain Thrombin Time Test Volume Forecasts by Market Segment
U.K. Thrombin Time Test Volume Forecasts by Market Segment
U.S.A. Thrombin Time Test Volume Forecasts by Market Segment